2026年5月，中国ADC赛道彻底炸了。5月6日，先声药业宣布其自主研发的靶向LRRC15的ADC药物注射用SIM0613获NMPA临床试验批准，拟开展晚期实体瘤研究。仅隔一天，诺诚健华的靶向CDH17新型ADCICP-B208也顺利拿到CDE临床批件。短短几天两款重磅新药接连获批！先声药业：LRRC15靶点新贵，手握10.6亿美元海外大单Guide ...

2025 年第一季度，全球医药交易市场呈现稳定态势，共计发生 231 笔交易，交易总金额约 675 亿美元，与 2024 年同期基本持平。中国在该季度医药交易数量达 75 笔，同比增长 34%；交易总金额高达 369 亿美元，较 2024 年同期增幅超 200%。无论是交易活跃度的提升 ...

Analog-to-digital converters (ADCs) are one of the most commonly used blocks in embedded systems. Applications of ADCs include current sensing, motor control, temperature sensing and a myriad of ...

With three dynamic tracks covering discovery, preclinical, clinical, and CMC, plus exclusive seminar days on ADC fundamentals and Bispecific ADCs, this guide ensures you gain critical insights and ...

Whether you're exploring emerging trends, novel payloads, or streamlined manufacturing strategies, this guide ensures you stay ahead in the ever-evolving ADC landscape. Download your copy now and ...